Focal Vibration for Enhancing Athletic Speed and Ppower

October 31, 2024 updated by: Maxim Canet Vintró, Universitat Internacional de Catalunya

Effectiveness of Focal Vibration in Enhancing Lower Extremity Speed and Power in Athletes

A focal vibration device will be used to perform an activation and warm-up protocol before performing a set of 7 repetitions of squat with 60% of your 1RM.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

72

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Study participants must have signed the informed consent form to assess their inclusion in the study.
  • Familiarity with the technique and practice of the weighted free squat.
  • Training at least 3 times per week.

Exclusion Criteria:

  • Volunteers who have suffered a sports injury during the last two months or are unable to perform physical activity.
  • Have previously received an intervention with focal vibration.
  • Not understanding the information provided by the therapist.
  • Participate in other research studies.
  • Be undergoing pharmacological medical treatment that may interfere with the measurements, such as treatment with anticonvulsants, antidepressants, etc.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Vibration group
The vibration group receives an intervention with focal vibration heads from Wintecare on the rectus femoris, vastus lateralis and vastus medialis , at the same time that the athelte is doing active muscle contractions.
Focal vibration is a 3x3 electrode placed on the athlete's muscle belly, and emits a high frequency vibration (150Hz) to stimulate the muscle spindle and generate greater muscle activation.
Other Names:
  • Local Vibration
Sham Comparator: Sham group
The placebo group receives the same protocol but the head of the focal vibration machine is not in contact with the patient's skin.
Is a focal vibration intervention but without conctact in the athelte's skin. Doing this we got a sham therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean Speed during squat
Time Frame: 1 minute

A linear transducer (Vitruve VBT) was used to measure the mean speed during the squat. The tether device was attached to the right side of the barbell around the widest part of the collar on the inside and this converts the subject's movement with the barbell into an electrical signal that will record the mean speed and of the exercise. Subjects will per-form 7 repetitions at 0,85 m/s at the maximum possible speed with the optimal load to generate the maximum power.

Linear transducers which have greater accuracy (5%) and reliability (ICC: 0.752; 95% CI: 0.548 - 0.855) compared to other devices in terms of velocity-based training (VBT) meas-urement.

1 minute
Mean Power during squat
Time Frame: 1 minute

A linear transducer (Vitruve VBT) was used to measure the mean power during the squat. The tether device was attached to the right side of the barbell around the widest part of the collar on the inside and this converts the subject's movement with the barbell into an electrical signal that will record the mean power of the exercise. Subjects will per-form 7 repetitions at 0,85 m/s at the maximum possible speed with the optimal load to generate the maximum power.

Linear transducers which have greater accuracy (5%) and reliability (ICC: 0.752; 95% CI: 0.548 - 0.855) compared to other devices in terms of velocity-based training (VBT) meas-urement.

1 minute

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Scale of perceived effort during squat
Time Frame: 1 minute
Just after the end of the series of 7 repetitions the sensation of effort perceived by the athlete was measured with the modified BORG scale (0-10), being 0 the lowest perceived effort and 10 being the highest effort.
1 minute
Participant's rating of clinical change. Global Rating of Change Scale (GROC scale).
Time Frame: 1 minute
At the end of the free bar squat after the warm-up and the intervention, the subject will be asked if he/she has felt improvement or worsening between the first time and the last time he/she performed the test. The participant's rating of clinical change will be evaluated with a Global Rating of Change Scale (GROC scale). This is a scale of 15 items, of which +7 are improvement and -7 are deterioration, and with 1 central item with no clinical change. Values from the fourth item of improvement or deterioration will be considered clinically significant, values between the three item of improvement and the three item of deterioration will be considered as no clinically significant changes. The test-retest reliability has proven to be good (ICC 0.90).
1 minute
Muscle Activity
Time Frame: 1 minute

Surface electromyography was used to evaluate the muscle activity of back and lower limb the during squatting task. The muscles assessed were vastus medialis, vastus lateralis, rectus femoris, biceps femoris, gluteus maximus and erector spinae longissimus. Data were obtained for the dominant limb defined as the one preferred to kick a ball.

the tool to be used is The mDurance® system (mDurance Solutions SL, Granada, Spain). The RMS was the principal variable recorded for muscle activity, expressed as % of MVIC (%MVIC).

1 minute

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 5, 2024

Primary Completion (Estimated)

November 30, 2024

Study Completion (Estimated)

December 6, 2024

Study Registration Dates

First Submitted

July 25, 2024

First Submitted That Met QC Criteria

October 31, 2024

First Posted (Estimated)

November 4, 2024

Study Record Updates

Last Update Posted (Estimated)

November 4, 2024

Last Update Submitted That Met QC Criteria

October 31, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • CBAS-2023-05

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe